Glenmark Pharma declines 9% on weak Q3 results
The stock fell 9% to Rs 524, its 52-week low on BSE trade after the company reported 78% fall in its consolidated net profit at Rs 1.05 billion for the quarter ended December 2017.
You may be interested
Pressure mounts on FCA boss Andrew Bailey over handling of RBS scandal reportwebmaster - February 17, 2018
Barwa Bank wins 2 titles at Global Banking & Finance Awards 2017 – Gulf Timeswebmaster - February 17, 2018
Barwa Bank wins 2 titles at Global Banking & Finance Awards 2017Gulf Times... and managing partner of Barwa Bank Group, said: “The “Best Shariah-Compliant Bank in Qatar”…